FDA/CDC

FDA backs Pfizer booster for 12- to 15-year-olds


 

Mixing and matching vaccines

Less clear at the moment is guidance about boosters for people who opted to mix and match their primary vaccine series.

“There was a mix-and-match study that was done which showed that in some cases, the mixing and matching … of an adenoviral record vaccine and an mRNA vaccine seem to give a very good immune response,” Dr. Marks said.

Once more data comes in on mixing and matching, “we’ll analyze them and then potentially make recommendations,” he said.

‘It’s not too late’

No federal government media briefing on COVID-19 would be complete without a plea for the unvaccinated to get immunized.

“We’re talking a lot about boosters right now, but it’s not too late for those who have not gotten a vaccine to get a vaccine,” Dr. Marks said, referring to the tens of millions of Americans who remain unvaccinated at the beginning of 2022.

“We know from our previous studies that even a single dose of the vaccine -- and probably two doses -- can help prevent the worst outcomes from COVID-19, including hospitalization and death.”

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

New studies suggest Omicron infections are less severe than Delta ones
MDedge Hematology and Oncology
Remdesivir may keep unvaccinated out of the hospital: Study
MDedge Hematology and Oncology
COVID booster protection may wane in about 10 weeks, new data show
MDedge Hematology and Oncology
Most cancer patients with breakthrough COVID-19 infection experience severe outcomes
MDedge Hematology and Oncology
Coronavirus can spread to heart, brain days after infection
MDedge Hematology and Oncology
NYC vaccine mandate for all businesses now in effect
MDedge Hematology and Oncology
COVID-19 antigen tests may be less sensitive to Omicron: FDA
MDedge Hematology and Oncology
COVID-19–positive or exposed? What to do next
MDedge Hematology and Oncology
Why patients should ditch cloth masks
MDedge Hematology and Oncology
Travel/school disruptions as COVID-19 cases grow in 2022
MDedge Hematology and Oncology